Home/Filings/4/0000899243-22-011386
4//SEC Filing

Ellis Andrea 4

Accession 0000899243-22-011386

CIK 0001743881other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:05 PM ET

Size

5.0 KB

Accession

0000899243-22-011386

Insider Transaction Report

Form 4
Period: 2022-03-15
Ellis Andrea
Director
Transactions
  • Purchase

    Common Stock

    2022-03-15$8.39/sh+12,000$100,68012,000 total
Footnotes (1)
  • [F1]Represents the weighted average purchase price of the shares purchased from $8.38 to $8.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions as reported in this footnote.

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1
  • filerCIK 0001877680

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:05 PM ET
Size
5.0 KB